Retinal Degeneration Fund
The Retinal Degeneration Fund (RD Fund) is a 501(c)(3) not-for-profit subsidiary of the Foundation Fighting Blindness, established in 2018 as its venture investment arm. With $122 million under management, the RD Fund focuses on making mission-related investments in companies developing treatments and cures for inherited retinal diseases and dry AMD, primarily targeting programs nearing clinical testing.
Raleigh, United States · 3+ investments · 2 portfolio companies
- Headquarters
- Raleigh, United States
- Founded
- 2018
- Website
- retinaldegenerationfund.org
- AUM
- $122.0M
- Portfolio Companies
- 2
- Total Investments
- 3
- Last Investment
- Jan 2026
- Geographic Focus
- Global
Investment Thesis
Retinal Degeneration Fund is a Venture Capital firm based in Raleigh, United States. It has made 3 investments in Biotech and Gene Therapy, including Perceive Bio and Amber.
Portfolio2
Co-investors17
Sign up to view co-investors
17 co-investors across 17 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×16 · Corporate VC ×1 · 8 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/retinal-degeneration-fund"><img src="https://indexed.vc/api/badge/investor/retinal-degeneration-fund" alt="Retinal Degeneration Fund on Indexed.vc" width="260" height="76" /></a>

